| |
STEMI
|
NSTEMI
|
|---|
|
OR
|
95% CI
|
OR
|
95% CI
|
|---|
|
GHR
|
|
Below proposed cut-off
|
1.00
|
Reference
|
1.00
|
Reference
|
|
Above proposed cut-off
|
2.28
|
1.80
|
2.89
|
1.30
|
0.92
|
1.83
|
|
Age in years
|
|
< 40
|
1.00
|
Reference
|
1.00
|
Reference
|
|
40–49
|
1.27
|
0.48
|
3.38
|
0.34
|
0.08
|
1.53
|
|
50–59
|
1.47
|
0.57
|
3.80
|
0.45
|
0.12
|
1.73
|
|
60–69
|
2.25
|
0.87
|
5.81
|
0.76
|
0.20
|
2.88
|
|
70–79
|
3.99
|
1.53
|
10.43
|
1.22
|
0.32
|
4.67
|
|
≥ 80
|
7.85
|
2.92
|
21.09
|
2.13
|
0.54
|
8.42
|
|
History of MI/PCI/CABG
|
|
No
|
1.00
|
Reference
|
1.00
|
Reference
|
|
Yes
|
1.19
|
0.90
|
1.59
|
1.53
|
1.12
|
2.10
|
|
Killip class on admission
|
|
I
|
1.00
|
Reference
|
1.00
|
Reference
|
|
II
|
1.49
|
0.96
|
2.31
|
2.86
|
1.95
|
4.21
|
|
III
|
2.46
|
1.66
|
3.66
|
3.22
|
2.09
|
4.93
|
|
IV
|
4.01
|
3.04
|
5.29
|
21.20
|
10.60
|
42.39
|
|
CPR on arrival
|
|
No
|
1.00
|
Reference
|
1.00
|
Reference
|
|
Yes
|
3.73
|
2.62
|
5.31
|
10.31
|
3.25
|
32.74
|
|
Creatinine in µmol/L
|
|
< 70
|
1.00
|
Reference
|
1.00
|
Reference
|
|
70–105
|
0.73
|
0.51
|
1.06
|
0.71
|
0.43
|
1.16
|
|
106–140
|
1.58
|
1.08
|
2.32
|
1.35
|
0.79
|
2.31
|
|
141–176
|
2.05
|
1.27
|
3.29
|
1.20
|
0.61
|
2.36
|
|
177–353
|
2.49
|
1.50
|
4.11
|
1.21
|
0.58
|
2.55
|
|
≥ 354
|
3.55
|
1.89
|
6.67
|
4.46
|
2.46
|
8.06
|
|
Haemoglobin in g/dL
|
|
< 10
|
1.00
|
Reference
|
1.00
|
Reference
|
|
10–11
|
1.21
|
0.68
|
2.14
|
1.27
|
0.72
|
2.21
|
|
12–13
|
0.81
|
0.47
|
1.41
|
1.10
|
0.61
|
1.96
|
|
14–15
|
0.56
|
0.32
|
0.99
|
0.44
|
0.22
|
0.88
|
|
≥ 16
|
0.67
|
0.37
|
1.24
|
0.42
|
0.16
|
1.10
|
- CABG coronary artery bypass grafting, CI confidence interval, GHR glucose-HbA1c ratio, MI myocardial infarction, NSTEMI non-ST-segment elevation myocardial infarction, OR odds ratio, PCI percutaneous coronary intervention, STEMI ST-segment elevation myocardial infarction
